Recall Register

Food, drugs, devices › Mindray DS USA, Inc. dba Mindray North America

Device recall: DPM 6 Monitor in use with a Multi Parameter Module (MPM). Patient monitor used for monitoring, displaying, reviewing, st

FDA enforcement event 67932 · Class II · initiated 5 Mar 2014 · status Terminated · terminated 27 Apr 2015

DeviceVoluntary: Firm initiated1 product recordMahwah, NJ

Mindray DS USA, Inc. dba Mindray North America (Mahwah, NJ) initiated this device recall on 5 Mar 2014; FDA lists 1 product record under event 67932, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,176 device enforcement events initiated in 2014 carry the same class.

Status: Terminated, terminated 27 Apr 2015. Initiation: voluntary: firm initiated. Mindray DS USA, Inc. dba Mindray North America has 29 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Mindray DS USA, Inc. dba Mindray North America, Mahwah, NJ.

Reason for recall

"The MPM included a cardiac ST/Arrhythmia analysis feature which is not cleared for marketing."

Distribution

"US Nationwide Distribution in the state of OH"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1611-2014DPM 6 Monitor in use with a Multi Parameter Module (MPM). Patient monitor used for monitoring, displaying, reviewing, storing, and alarming of multiple physiological parameters including ECG, arrhythmia detection, ST segment analysis, heart rate (HR), respiration rate (RESP), temperature, pulse oxygen saturation…4 unitsClass IITerminated21 May 2014

Context

91%of 2014 device events are Class II1,176 events that year
1product record in this eventfirm median: 1
29events on this register for the firm

Other enforcement events for Mindray DS USA, Inc. dba Mindray North America

InitiatedProduct (first record)TypeClassRecords
18 Nov 2025Hardware configuration of the BeneVision Central Monitoring System (CMS), marketed as BeneVision Distributed Monitoring DeviceClass II1
20 Oct 2025Sevoflurane (SEVO) V90 Electronic Vaporizer with the A9 Anesthesia System. Labeled as the following: 1. Sev E_Vap. (SafeDeviceClass II2
15 Aug 2025BeneVision N1 Patient Monitor (N1). Part Numbers: 6660E-PA00017, 6660E-PA00014, 6660E-PA00012, 6660E-PA00011, 6660E-PA00DeviceClass II1
22 Jul 2024Sevoflurane E_Vap.(Quik-Fil):used with the A9 Anesthesia System-Used to provide the vapor of an anesthetic agent with coDeviceClass II4
27 May 20213AA battery cradle (Part Number 045-001699-01) used with BeneVision TD60 Telepack (Model Number 115-047566-00 /115-06004DeviceClass III1
22 Feb 2021Mindray BeneVision Distributed Monitoring System( DMS) 1. p/n 115-051209-00 2. p/n 115-034414-00 and 115-034413-00 when DeviceClass II1
13 Jan 2020DP-30 Digital Ultrasonic Diagnostic Imaging System, Part No. 1155E-PA00004 - Product Usage: The Digital Ultrasonic DiagnDeviceClass II1
9 Dec 2019BA-800M Chemistry Analyzer Part Numbers BA81E-PA00002 and BA81E-PA00003, Containing Gas spring YQ-8/18-90-272-180N (MateDeviceClass II2
1 Oct 2019Accutorr 3 Vital Signs Monitor with NIBP valve assembly board, p/n 115-017679-00, containing software version 8.1.5 - PrDeviceClass II4
30 Aug 2018Mindray BeneVision Distributed Monitoring System (DMS), Part No. 115-034413-00DeviceClass II1

All 29 events for Mindray DS USA, Inc. dba Mindray North America

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The MPM included a cardiac ST/Arrhythmia analysis feature which is not cleared for marketing."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide Distribution in the state of OH"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 27 Apr 2015. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.